|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: GENOME THERAPEUTICS CORP, 10-Q, 2000-07-11 |
Next: FLORIDA PROGRESS CORP, DEFM14A, 2000-07-11 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> AUG-31-2000
<PERIOD-START> SEP-01-1999
<PERIOD-END> MAY-27-2000
<CASH> 19,198
<SECURITIES> 11,157
<RECEIVABLES> 405
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 32,158
<PP&E> 27,604
<DEPRECIATION> 14,022
<TOTAL-ASSETS> 47,795
<CURRENT-LIABILITIES> 12,498
<BONDS> 4,781
0
0
<COMMON> 2,062
<OTHER-SE> 28,454
<TOTAL-LIABILITY-AND-EQUITY> 47,795
<SALES> 20,318
<TOTAL-REVENUES> 20,318
<CGS> 0
<TOTAL-COSTS> 22,054
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (653)
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,084)
<EPS-BASIC> (.05)
<EPS-DILUTED> (.05)
</TABLE>
|
|